Review





Similar Products

95
Chem Impex International boc β alanine
Boc β Alanine, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/boc β alanine/product/Chem Impex International
Average 95 stars, based on 1 article reviews
boc β alanine - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

86
Macklin Inc n boc o tert butyl l tyrosine
N Boc O Tert Butyl L Tyrosine, supplied by Macklin Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/n boc o tert butyl l tyrosine/product/Macklin Inc
Average 86 stars, based on 1 article reviews
n boc o tert butyl l tyrosine - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Iris Biotech Gmbh fmoc lys boc oh
Fmoc Lys Boc Oh, supplied by Iris Biotech Gmbh, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fmoc lys boc oh/product/Iris Biotech Gmbh
Average 86 stars, based on 1 article reviews
fmoc lys boc oh - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

95
Chem Impex International boc 2 aminobenzoic acid
Boc 2 Aminobenzoic Acid, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/boc 2 aminobenzoic acid/product/Chem Impex International
Average 95 stars, based on 1 article reviews
boc 2 aminobenzoic acid - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

93
Tocris boc mlf
ELISA assays in the supernatant of the axon chambers. NTC: no-treatment control; a-TLR+PA: the axon chamber pretreated with TLR4-specific antagonist, LPS-RS Ultrapure (20 µg/mL) 2 hours before PA infection; a-Fpr+PA: the axon chamber pre-treated with Fpr1 <t>antagonist,</t> <t>Boc-MLF</t> (2 µg/mL) 2 hours before PA infection; a-TLR/Fpr+PA: the axon chamber pre-treated with both LPS-RS Ultrapure (20 µg/mL) and Fpr1 antagonist, Boc-MLF (2 µg/mL) 2 hours before PA infection. *: p<0.05, **: p<0.01, ***:p<0.001 by one-way ANOVA of multiple sample comparison with Bonferroni post hoc test. #: p<0.05, ##: p<0.01, ###: p<0.001 by Student’s t test.
Boc Mlf, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/boc mlf/product/Tocris
Average 93 stars, based on 1 article reviews
boc mlf - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

86
Combi-Blocks Inc boc asp oh
ELISA assays in the supernatant of the axon chambers. NTC: no-treatment control; a-TLR+PA: the axon chamber pretreated with TLR4-specific antagonist, LPS-RS Ultrapure (20 µg/mL) 2 hours before PA infection; a-Fpr+PA: the axon chamber pre-treated with Fpr1 <t>antagonist,</t> <t>Boc-MLF</t> (2 µg/mL) 2 hours before PA infection; a-TLR/Fpr+PA: the axon chamber pre-treated with both LPS-RS Ultrapure (20 µg/mL) and Fpr1 antagonist, Boc-MLF (2 µg/mL) 2 hours before PA infection. *: p<0.05, **: p<0.01, ***:p<0.001 by one-way ANOVA of multiple sample comparison with Bonferroni post hoc test. #: p<0.05, ##: p<0.01, ###: p<0.001 by Student’s t test.
Boc Asp Oh, supplied by Combi-Blocks Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/boc asp oh/product/Combi-Blocks Inc
Average 86 stars, based on 1 article reviews
boc asp oh - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

95
Chem Impex International boc his tos oh n α tert butoxycarbonyl n τ tosylhistidine
ELISA assays in the supernatant of the axon chambers. NTC: no-treatment control; a-TLR+PA: the axon chamber pretreated with TLR4-specific antagonist, LPS-RS Ultrapure (20 µg/mL) 2 hours before PA infection; a-Fpr+PA: the axon chamber pre-treated with Fpr1 <t>antagonist,</t> <t>Boc-MLF</t> (2 µg/mL) 2 hours before PA infection; a-TLR/Fpr+PA: the axon chamber pre-treated with both LPS-RS Ultrapure (20 µg/mL) and Fpr1 antagonist, Boc-MLF (2 µg/mL) 2 hours before PA infection. *: p<0.05, **: p<0.01, ***:p<0.001 by one-way ANOVA of multiple sample comparison with Bonferroni post hoc test. #: p<0.05, ##: p<0.01, ###: p<0.001 by Student’s t test.
Boc His Tos Oh N α Tert Butoxycarbonyl N τ Tosylhistidine, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/boc his tos oh n α tert butoxycarbonyl n τ tosylhistidine/product/Chem Impex International
Average 95 stars, based on 1 article reviews
boc his tos oh n α tert butoxycarbonyl n τ tosylhistidine - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

86
Shanghai Aladdin Bio-Chem dimethylethoxy carbonyl l alanyl l alanine boc alaoh
ELISA assays in the supernatant of the axon chambers. NTC: no-treatment control; a-TLR+PA: the axon chamber pretreated with TLR4-specific antagonist, LPS-RS Ultrapure (20 µg/mL) 2 hours before PA infection; a-Fpr+PA: the axon chamber pre-treated with Fpr1 <t>antagonist,</t> <t>Boc-MLF</t> (2 µg/mL) 2 hours before PA infection; a-TLR/Fpr+PA: the axon chamber pre-treated with both LPS-RS Ultrapure (20 µg/mL) and Fpr1 antagonist, Boc-MLF (2 µg/mL) 2 hours before PA infection. *: p<0.05, **: p<0.01, ***:p<0.001 by one-way ANOVA of multiple sample comparison with Bonferroni post hoc test. #: p<0.05, ##: p<0.01, ###: p<0.001 by Student’s t test.
Dimethylethoxy Carbonyl L Alanyl L Alanine Boc Alaoh, supplied by Shanghai Aladdin Bio-Chem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dimethylethoxy carbonyl l alanyl l alanine boc alaoh/product/Shanghai Aladdin Bio-Chem
Average 86 stars, based on 1 article reviews
dimethylethoxy carbonyl l alanyl l alanine boc alaoh - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

95
Chem Impex International boc lysine chem impex
ELISA assays in the supernatant of the axon chambers. NTC: no-treatment control; a-TLR+PA: the axon chamber pretreated with TLR4-specific antagonist, LPS-RS Ultrapure (20 µg/mL) 2 hours before PA infection; a-Fpr+PA: the axon chamber pre-treated with Fpr1 <t>antagonist,</t> <t>Boc-MLF</t> (2 µg/mL) 2 hours before PA infection; a-TLR/Fpr+PA: the axon chamber pre-treated with both LPS-RS Ultrapure (20 µg/mL) and Fpr1 antagonist, Boc-MLF (2 µg/mL) 2 hours before PA infection. *: p<0.05, **: p<0.01, ***:p<0.001 by one-way ANOVA of multiple sample comparison with Bonferroni post hoc test. #: p<0.05, ##: p<0.01, ###: p<0.001 by Student’s t test.
Boc Lysine Chem Impex, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/boc lysine chem impex/product/Chem Impex International
Average 95 stars, based on 1 article reviews
boc lysine chem impex - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

Image Search Results


ELISA assays in the supernatant of the axon chambers. NTC: no-treatment control; a-TLR+PA: the axon chamber pretreated with TLR4-specific antagonist, LPS-RS Ultrapure (20 µg/mL) 2 hours before PA infection; a-Fpr+PA: the axon chamber pre-treated with Fpr1 antagonist, Boc-MLF (2 µg/mL) 2 hours before PA infection; a-TLR/Fpr+PA: the axon chamber pre-treated with both LPS-RS Ultrapure (20 µg/mL) and Fpr1 antagonist, Boc-MLF (2 µg/mL) 2 hours before PA infection. *: p<0.05, **: p<0.01, ***:p<0.001 by one-way ANOVA of multiple sample comparison with Bonferroni post hoc test. #: p<0.05, ##: p<0.01, ###: p<0.001 by Student’s t test.

Journal: bioRxiv

Article Title: The miR-183/96/182 Cluster Regulates Trigeminal Ganglion Sensory Neurons’ Response to Pseudomonas aeruginosa Infection

doi: 10.64898/2026.03.30.715374

Figure Lengend Snippet: ELISA assays in the supernatant of the axon chambers. NTC: no-treatment control; a-TLR+PA: the axon chamber pretreated with TLR4-specific antagonist, LPS-RS Ultrapure (20 µg/mL) 2 hours before PA infection; a-Fpr+PA: the axon chamber pre-treated with Fpr1 antagonist, Boc-MLF (2 µg/mL) 2 hours before PA infection; a-TLR/Fpr+PA: the axon chamber pre-treated with both LPS-RS Ultrapure (20 µg/mL) and Fpr1 antagonist, Boc-MLF (2 µg/mL) 2 hours before PA infection. *: p<0.05, **: p<0.01, ***:p<0.001 by one-way ANOVA of multiple sample comparison with Bonferroni post hoc test. #: p<0.05, ##: p<0.01, ###: p<0.001 by Student’s t test.

Article Snippet: To test this hypothesis, we pre-treated the neurites in the axon chambers with a TLR4-specific antagonist, TLR4-RS (InVivoGen), and/or a FPR1-specific antagonist, Boc-MLF (TOCRIS) 2 hours before PA infection.

Techniques: Enzyme-linked Immunosorbent Assay, Control, Infection, Comparison

ELISA assays in the cell lysates of the soma chambers. NTC: no treatment control; a-TLR+PA: axon chambers pretreated with TLR4-specific antagonist, LPS-RS Ultrapure (20 µg/mL) 2 hours before PA infection; a-Fpr+PA:, the axon chambers pre-treated with Fpr1 antagonist, Boc-MLF (2 µg/mL) 2 hours before PA infection; a-TLR/Fpr+PA: axon chambers pre-treated with LPS-RS Ultrapure (20 µg/mL) and Boc-MLF (2 µg/mL) 2 hours before PA infection. *: p<0.05, **: p<0.01, ***:p<0.001 by one-way ANOVA of multiple sample comparison with Bonferroni post hoc test. #: p<0.05, ##: p<0.01, ###: p<0.001 by Student’s t test.

Journal: bioRxiv

Article Title: The miR-183/96/182 Cluster Regulates Trigeminal Ganglion Sensory Neurons’ Response to Pseudomonas aeruginosa Infection

doi: 10.64898/2026.03.30.715374

Figure Lengend Snippet: ELISA assays in the cell lysates of the soma chambers. NTC: no treatment control; a-TLR+PA: axon chambers pretreated with TLR4-specific antagonist, LPS-RS Ultrapure (20 µg/mL) 2 hours before PA infection; a-Fpr+PA:, the axon chambers pre-treated with Fpr1 antagonist, Boc-MLF (2 µg/mL) 2 hours before PA infection; a-TLR/Fpr+PA: axon chambers pre-treated with LPS-RS Ultrapure (20 µg/mL) and Boc-MLF (2 µg/mL) 2 hours before PA infection. *: p<0.05, **: p<0.01, ***:p<0.001 by one-way ANOVA of multiple sample comparison with Bonferroni post hoc test. #: p<0.05, ##: p<0.01, ###: p<0.001 by Student’s t test.

Article Snippet: To test this hypothesis, we pre-treated the neurites in the axon chambers with a TLR4-specific antagonist, TLR4-RS (InVivoGen), and/or a FPR1-specific antagonist, Boc-MLF (TOCRIS) 2 hours before PA infection.

Techniques: Enzyme-linked Immunosorbent Assay, Control, Infection, Comparison